Literature DB >> 29773306

Factors Associated with Timing and Adverse Outcomes in Patients with Biliary Atresia Undergoing Kasai Hepatoportoenterostomy.

Michael Ross Townsend1, Adeeb Jaber2, Hanina Abi Nader2, Shaker M Eid2, Kathleen Schwarz3.   

Abstract

OBJECTIVE: To assess factors associated with timing of hepatoportoenterostomy (HPE) and adverse perioperative outcomes in patients with biliary atresia in the US. STUDY
DESIGN: We examined hospitalizations in infants aged <1 year using the National Inpatient Sample database for 2000-2011. We identified cases using the International Classification of Diseases, Ninth Revision, Clinical Modification codes for biliary atresia and HPE. Multivariable logistic regression models were used to examine association between select factors and age at HPE, as well as adverse perioperative outcomes.
RESULTS: Our analysis of 1243 biliary atresia hospitalizations showed that only 37.7% of patients had HPE in the first 60 days of life. Patients who underwent HPE after 60 days of age were uninsured, were more likely to be black (aOR, 4.22; 95% CI, 1.49-11.95), less likely to be admitted at a teaching hospital (aOR, 0.27; 95% CI 0.10-0.79), and less likely to have a concomitant congenital malformation (aOR, 0.49; 95% CI 0.25-0.98). Patients with delayed age at HPE incurred significantly higher hospital costs ($57 914 vs $34 074; P = .026). Delayed age at HPE and weekend admission were independently associated with increased odds of adverse perioperative outcome (aOR, 1.09; 95% CI, 1.01-3.02 and 3.98; 95% CI, 1.67-9.46, respectively).
CONCLUSION: Current outcomes in patients with biliary atresia in the United States are suboptimal and result in higher costs. The specific factors associated with delayed care are further evidence that universal health care and screening are needed for all infants, along with systematic referral of potential patients with biliary atresia to specialized health centers.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Kasai hepatoportoenterostomy; biliary atresia; healthcare cost and utilization project; nationwide inpatient sample; outcomes; trends

Mesh:

Year:  2018        PMID: 29773306     DOI: 10.1016/j.jpeds.2018.04.001

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

Review 1.  Impact of early Kasai portoenterostomy on short-term outcomes of biliary atresia: A systematic review and meta-analysis.

Authors:  Changzhen Yang; Meng Ke; Yan Zhou; Hang Xu; Mei Diao; Long Li
Journal:  Front Surg       Date:  2022-09-01

Review 2.  Peri-Operative Liver Fibrosis and Native Liver Survival in Pediatric Patients with Biliary Atresia: A Systematic Review and Meta-Analysis.

Authors:  Ashkan Jahangirnia; Irina Oltean; Youssef Nasr; Nayaar Islam; Arielle Weir; Joseph de Nanassy; Ahmed Nasr; Dina El Demellawy
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2022-09-05

3.  Effects of postoperative adjuvant steroid therapy on the outcomes of biliary atresia: A systematic review and updated meta-analysis.

Authors:  Chang-Zhen Yang; Yan Zhou; Meng Ke; Ru-Yue Gao; Shi-Ru Ye; Mei Diao; Long Li
Journal:  Front Pharmacol       Date:  2022-09-14       Impact factor: 5.988

4.  Predictors of Short-Term Outcome of Kasai Portoenterostomy for Biliary Atresia in Infants: a Single-Center Study.

Authors:  Noha Adel Yassin; Gamal El-Tagy; Omar Nagy Abdelhakeem; Noha Asem; Hanaa El-Karaksy
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2020-05-13

5.  Commentary-Update on disorders of the gastrointestinal tract in children, part II.

Authors:  Maged Ramsy
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2020-09-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.